Regenetp (STU:NJT) Days Payable : 0.00 (As of Mar. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Regenetp Days Payable?

Regenetp's average Accounts Payable for the three months ended in Mar. 2023 was €0.33 Mil. Regenetp's Cost of Goods Sold for the three months ended in Mar. 2023 was €0.00 Mil.

The historical rank and industry rank for Regenetp's Days Payable or its related term are showing as below:

STU:NJT's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.28
* Ranked among companies with meaningful Days Payable only.

Regenetp's Days Payable declined from Mar. 2022 (81.84) to Mar. 2023 (0.00). It may suggest that Regenetp accelerated paying its suppliers.

Regenetp Days Payable Historical Data

The historical data trend for Regenetp's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenetp Days Payable Chart

Regenetp Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Oct17

Oct18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

443.90

267.16

125.50

54.18

184.07

Regenetp Quarterly Data
	Apr18	Jul18	Oct18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Days Payable	Get a 7-Day Free Trial															81.84	425.70	-	-	-

Competitive Comparison of Regenetp's Days Payable

For the Biotechnology subindustry, Regenetp's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenetp's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenetp's Days Payable distribution charts can be found below:

* The bar in red indicates where Regenetp's Days Payable falls into.

Regenetp Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Regenetp's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (0.153	+	0.433)	/	2 )	/	0.581	*	365
=	0.293					/	0.581	*	365
=	184.07

Regenetp's Days Payable for the quarter that ended in Mar. 2023 is calculated as:

	Days Payable (Q: Mar. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2023 )	*	Days in Period
=	( (0.433	+	0.228)	/	2 )	/	0	*	365 / 4
=	0.3305					/	0	*	365 / 4
=	N/A

Regenetp Days Payable Related Terms

Thank you for viewing the detailed overview of Regenetp's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenetp (STU:NJT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenetp Inc (STU:NJT) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

RGTPQ:USA

Address

1960 South 4250 West, Salt Lake City, UT, USA, 84104

Website

https://www.polarityte.com

Regenetp Inc Formerly PolarityTE Inc is a clinical-stage biotechnology company developing regenerative tissue products and biomaterials. It's focused on transforming the lives of patients by discovering, designing, and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. Its product includes SkinTE used for repair, reconstruction, replacement, or regeneration of the skin in patients who have or require treatment of acute and chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. It operates in two segments: the regenerative medicine business segment and the contract research segment.

Regenetp (STU:NJT) Headlines

No Headlines